Antitumor agent-159 (CAY10726) targets mitochondria and downregulates cardiolipin levels; inhibits proliferation of MDA-MB-231 cancer cells, induces cell cycle arrest at sub-G1 phase, and triggers apoptosis in MDA-MB-231 cells; exhibits antitumor activity in an MDA-MB-231 xenograft mouse model.